Neuroblastoma On-line Researcher's Forum

Recent Publications About Neuroblastoma


This page is intended for physicians and research scientists.

ISSUE: 1999/07/a To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Contents

References: Clinical / Prognostic Markers
References: Basic Science / Research
Previous Issue of Recent Publications (1999/06/a)
Next Issue of Recent Publications (1999/08/a)
Back to NBL-PROF Home Page

Clinical / Prognostic Markers

Gallego S, et al. Clinical relevance of molecular markers in neuroblastoma: results from a single institution. Oncol Rep. 1999 Jul-Aug;6(4):891-6.    [Related articles]

Koseoglu V, et al. Neuroblastoma with spermatic cord metastasis in a child: sonographic findings. J Clin Ultrasound. 1999 Jun;27(5):287-9.    [Related articles]

Fortney JT, et al. Anesthesia for pediatric external beam radiation therapy. Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):587-91.    [Related articles]

Castleberry RP. Predicting outcome in neuroblastoma. N Engl J Med. 1999;340(25):1992-3.    [Related articles]
+See also: Chromosome 17q

Castleberry RP. Consistently investigating the inconsistent nature of neuroblastoma. J Pediatr Hematol Oncol. 1999 May-Jun;21(3):178-80.    [Related articles]

Yokoyama S, et al. Neuroblastoma of the urinary bladder, preclinically detected by mass screening. Pediatrics. 1999 May;103(5):e67.    [Related articles]
+See also: Screening

Leung CK. Fifteen years' review of advanced childhood neuroblastoma from a single institution in Hong Kong. Chin Med J (Engl). 1998 May;111(5):466-9.    [Related articles]

Ihara K, et al. Rubinstein-Taybi syndrome: a girl with a history of neuroblastoma and premature thelarche. Am J Med Genet. 1999 Apr 23;83(5):365-6.    [Related articles]

Frostad B, et al. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children. Cancer. 1999 Apr 25;87(2):60-8.    [Related articles]

Bessho F. Comparison of the incidences of neuroblastoma for screened and unscreened cohorts. Acta Paediatr. 1999 Apr;88(4):404-6.    [Related articles]
+See also: Screening

Basic Science / Research

Maurer BJ, et al. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst. 1999 Jul 7;91(13):1138-46.    [Related articles]

Yanagisawa T, et al. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma. Br J Cancer. 1999 Jun;80(8):1190-6.    [Related articles]

Solovyan V, et al. Distinct mechanisms underlay DNA disintegration during apoptosis induced by genotoxic and nongenotoxic agents in neuroblastoma cells. Neurochem Int. 1999;34(6):465-72.    [Related articles]

Shimizu M, et al. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells. J Immunol. 1999 Jun 15;162(12):7350-7.    [Related articles]

Ronca F, et al. Retinoic acid confers resistance to p53-dependent apoptosis in SH-SY5Y neuroblastoma cells by modulating nuclear import of p53. J Biol Chem. 1999 Jun 18;274(25):18128-34.    [Related articles]

Miyachi T, et al. Structure and regulation of the human NeuroD (BETA2/BHF1) gene. Brain Res Mol Brain Res. 1999 Jun 8;69(2):223-31.    [Related articles]

Lebeda RA, et al. Transcriptional regulation of the human ADP-ribosylation factor 5 (ARF5) gene. Biochim Biophys Acta. 1999 Jun 9;1445(3):314-320.    [Related articles]

Dimitroulakos J, et al. Identification of a novel zinc finger gene, zf5-3, as a potential mediator of neuroblastoma differentiation. Int J Cancer. 1999 Jun 11;81(6):970-8.    [Related articles]

Amari L, et al. Competition between Li+ and Mg2+ in neuroblastoma SH-SY5Y cells: A fluorescence and 31P NMR study. Biophys J. 1999 Jun;76(6):2934-42.    [Related articles]

Toda M, et al. Suppression of an actin-binding protein, drebrin, by antisense transfection attenuates neurite outgrowth in neuroblastoma B104 cells. Brain Res Dev Brain Res. 1999 May 14;114(2):193-200.    [Related articles]

Pijuan-Thompson V, et al. Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. Exp Cell Res. 1999 May 25;249(1):86-101.    [Related articles]

Oras A, et al. Influence of atropine on carbachol dual effect on Ca2+ mobilization in SH-SY5Y neuroblastoma cells. Biochem Mol Biol Int. 1999 May;47(5):743-7.    [Related articles]

Kemler I, et al. Role of IkappaBalpha and IkappaBbeta in the biphasic nuclear translocation of NF-kappaB in TNFalpha-stimulated astrocytes and in neuroblastoma cells. Glia. 1999 May;26(3):212-20.    [Related articles]

Hafer R, et al. Neuroblastoma cells can express the hematopoietic progenitor cell antigen CD34 as detected at surface protein and mRNA level. J Neuroimmunol. 1999 May 3;96(2):201-6.    [Related articles]

Diehlmann A, et al. Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies. J Neurosci Res. 1999 May 15;56(4):405-19.    [Related articles]

Davidoff AM, et al. Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12. J Pediatr Surg. 1999 May;34(5):902-6; discussion 906-7.    [Related articles]

Barber D, et al. Comparative effectiveness of organophosphorus protoxicant activating systems in neuroblastoma cells and brain homogenates. J Toxicol Environ Health. 1999 May 14;57(1):63-74.    [Related articles]

Wang JF, et al. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience. 1999 Apr;91(2):771-6.    [Related articles]

Sidhu A, et al. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells. Neuroscience. 1999 Apr;91(2):537-47.    [Related articles]

Rehberg B, et al. Sodium channels (from rat, mouse, and man) in neuroblastoma cells and different expression systems have similar sensitivities to pentobarbital. Neurosci Lett. 1999 Apr 2;264(1-3):81-4.    [Related articles]

Olianas MC, et al. [Phe1phi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells. Neuroreport. 1999 Apr 6;10(5):1127-31.    [Related articles]
+See also: Chromosome 1p

Martin AK, et al. Complex relationship between Ins(1,4,5)P3 accumulation and Ca2+ -signalling in a human neuroblastoma reveled by cellular differentiation. Br J Pharmacol. 1999 Apr;126(7):1559-66.    [Related articles]

Lazarova DL, et al. HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts. Oncogene. 1999 Apr 29;18(17):2703-10.    [Related articles]
+See also: MYCN Amplification

Helmeste DM, et al. Binding of [3H]U-101958 to sigma1 receptor-like sites in human cerebellum and neuroblastoma cells. Eur J Pharmacol. 1999 Apr 9;370(2):205-9.    [Related articles]

Girgert R, et al. Growth inhibition of neuroblastoma cells by lovastatin and L-ascorbic acid is based on different mechanisms. Cancer Lett. 1999 Apr 1;137(2):167-72.    [Related articles]

Akiyama K, et al. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines. Biochem Mol Biol Int. 1999 Apr;47(4):563-8.    [Related articles]
+See also: MYCN Amplification

Macaulay RJ, et al. Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro. J Neurooncol. 1999 Mar;42(1):1-11.    [Related articles]

Schor NF. Neuroblastoma as a neurobiological disease. J Neurooncol. 1999 Jan;41(2):159-66. Review.    [Related articles]

Previous Issue of Recent Publications (1999/06/a)
Next Issue of Recent Publications (1999/08/a)
Back to NBL-PROF Home Page